Proteus

Protéus is a well-known leading company in the discovery and development of novel proteins and biocatalysts. Biodiversity screening and protein engineering are the two rewarding complementary approaches used to make proteins available that are tailored to the application targeted. Proprietary technologies includes protein expression, a unique biodiversity and a proven gene shuffling technology

Activity:

- Contract Research
- Research & Development

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Enzymes
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Proteins

Therapeutic targets:

Markets Covered

a. HeadQuarter: France

b. Continent(s) active: Europe , North America , Far East

c. Countries active: Germany, The Netherlands, Swizerland, France, etc.

Corporate data:

Number of Employees: 35

Turnover:

Amount:	Year:	Currency:
3m	2002	Euro

Year founded: 1998

Partners / Alliances: Protéus’ industrial partners are major players on large markets such as pharmaceuticals fine chemicals or consumer goods. Since inception in 1998, Protéus has entered into several industrial partnerships with leading companies including Aventis, Degussa, Henkel, Thales, etc. Certain partnerships have become strategic alliances to discover and commercialize innovative products for an entire domain of application.